A new report from a leading specialist has suggested that some of the hearing aids being sold as “agx” or “clear” hearing aids might actually be more sensitive to the impact of trauma than most of the devices currently on the market.

Read moreA team of researchers led by Dr Francesco Giannini at the University of Padova in Italy, from which the report was published, analysed the data from over 2,000 hearing aid purchasers, comparing them to the responses of their hearing aid providers.

The results, which were published in the latest edition of the Journal of Clinical Hearing Research, showed that the more sensitive the hearing aid was to the amount of trauma it was used for, the less likely it was to work as a “clear hearing aid”.

The research was based on an assessment of the response of the average consumer to hearing aids in three different hearing aids: an Agx 3.5, an Agex-5 and an Agxs hearing aid.

According to the researchers, there was a clear benefit to buying a hearing aid with an Aglex hearing aid in terms of its ability to reduce the likelihood of hearing loss, and therefore improve the hearing of people who had suffered a traumatic event.

The most sensitive hearing aid to trauma was the Agx-3, which was the most sensitive of all three.

The study found that in contrast to hearing aid users who were most sensitive to trauma, there were only two consumers who were not.

“These results suggest that for people with hearing loss who are seeking an agx-5, it is not necessary to buy the most expensive hearing aid because the AgX-3 is the most powerful,” the researchers concluded.

“In terms of safety, however, the Ag-5 is far safer than the Agax and Agx hearing aid.”

The findings are consistent with research that has been published in recent years which has found that the Agxs, Agx, AgX2, Agex and Agxx hearing aids all work similarly to the Agps hearing aid, which has been widely recommended by the Royal College of Hearing Aid (RCHA) as a better choice for people.

This is the first study to compare the results of the two types of hearing aids and it is important to note that the authors do not claim that the findings apply to all types of Agx devices.

They have therefore conducted a follow-up study to check the safety of the Agex hearing aid for the use of hearing impaired people, but they found no evidence that the device was more likely to cause hearing loss.

“It is important for the public to understand that there are no clear-cut answers to the question of whether the use and use of the different hearing aid types may be associated with a higher risk of hearing impairment,” they wrote.

“The most widely used hearing aid may have a higher level of sensitivity to the hearing loss it is intended for, but that is because the hearing protection devices we use are designed to work with hearing.”

“We also believe that it is critical to consider the possibility that there may be an association between the use patterns of different hearing protection products and the frequency of hearing injury experienced in the future,” they added.

“While this study is the earliest work to examine this issue, there are currently no studies on this issue in the medical literature, and no clear evidence to suggest that the use or use of different types of sound therapy products may be linked to the risk of the development of hearing impairments in the general population.”